Back

Exploring and managing pulmonary hypertension in congenital heart defects: a challenging path

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 4 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joao Fernandes Pedro

Santa Maria Hospital - CHULN, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Unveiling the interplay of pulmonary hypertension parameters from right heart catheterization with cardiopulmonary exercise testing in heart failure patients
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Unmasking exercise pulmonary hypertension - does time matter?
Doctor J. Mirinha Luz (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Characteristics, outcomes, and risk stratification in obese vs. non-obese patients with pulmonary arterial hypertension
Doctor G. Savonitto (Stockholm, IT)
Abstract Slides Video
Presentation thumbnail
The unusual suspect. Is pulmonary veno-occlusive disease underrecognized?
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Early treatment failure in incident pulmonary arterial hypertension
Doctor G. Savonitto (Stockholm, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Adults with congenital heart disease and pulmonary arterial hypertension: Quantitative assessment of haemodynamic parameters under disease targeting therapy - A retrospective multicentre analysis
thumbnail
Congress Presentation
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease
thumbnail
Congress Presentation
Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources